A Study of LY2624803 in Japanese Participants With Transient Insomnia

Inclusion Criteria: * Overtly healthy males or female Japanese * Women of child-bearing potential, who test negative for pregnancy at the time of enrollment based on a urine pregnancy test and agree to use a reliable method of birth control during the study and for 3 months following the last dose of study drug * Body mass index (BMI) of 17.6 to 26.4 kilogram per meter square (kg/m\^2), inclusive * Normal bedtime hours, with routine time spent in bed between 6.5 hours and 9 hours each night * Clinical laboratory test results within normal reference range * Venous access sufficient to allow blood sampling as per the protocol * Are reliable and willing to make themselves available for the duration of the study and are willing and able to follow study procedures * Have given written informed consent approved by Lilly and the ethical review board governing the site Exclusion Criteria: * Within 4 months of the initial dose of study drug, have received treatment with a drug that has not received regulatory approval for any indication * Persons who have previously completed or withdrawn from this study or any other study investigating LY2624803 after receiving study drug * Known allergies to LY2624803 or related compounds * Women who are lactating * Shift workers \[those who shifted or plan to shift work within 7 days of any phase advance polysomnography (PSG) night\] or any person who has crossed (or will have crossed) more than one time zone by aircraft within 3 days prior to e…